Effects of growth hormone and testosterone therapy on aerobic and anaerobic fitness, body composition and lipoprotein profile in middle-aged men.

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

The aim of this research project was to evaluate the effects of recombinant human growth hormone and testosterone enanthate injections on body mass and body composition, aerobic and anaerobic fitness and lipid profile in middle-aged men.

Who Took Part

The abstract describes 14 men taking part.

The age groups tagged for this paper are middle-aged adults, men only.

The research group was comprised of 14 men aged 45 - 60 years.

How the Study Was Run

The design is described as randomized.

The men were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

Two series of laboratory analyses were performed.

The data were analyzed using Statistica 9.1 software.

What Was Measured

The subject headings attached to it are Androgens, Body Composition, Human Growth Hormone, Injections, Lipid Metabolism, Lipoproteins and Physical Fitness.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 14 men.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2014 (Annals of agricultural and environmental medicine : AAEM), a journal based in Poland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.